Safety & effectiveness of COVID-19 vaccines: A narrative review

被引:40
|
作者
Chirico, Francesco [1 ,4 ]
Teixeira da Silva, Jaime A.
Tsigaris, Panagiotis [2 ]
Sharun, Khan [3 ]
机构
[1] Univ Cattolica Sacro Cuore, Postgrad Sch Occupat Med, Dept Publ Hlth, Rome, Italy
[2] Thompson Rivers Univ, Dept Econ, Kamloops, BC, Canada
[3] Indian Vet Res Inst, Div Surg, ICAR, Bareilly, Uttar Pradesh, India
[4] Via Umberto Cagni 21, I-20162 Milan, Italy
关键词
Adverse effect; clinical trials; COVID-19; efficacy; neutralization potential; risks; safety; SARS-CoV-2; NCOV-19; AZD1222; VACCINE; SARS-COV-2; IMPLICATIONS; EFFICACY; THROMBOSIS; VARIANT; NEED;
D O I
10.4103/ijmr.IJMR_474_21
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
There are currently eight vaccines against SARS-CoV-2 that have received Emergency Use Authorization by the WHO that can offer some protection to the world's population during the COVID-19 pandemic. Though research is being published all over the world, public health officials, policymakers and governments are collecting evidence-based information to establish the public health policies. Unfortunately, continued international travel, violations of lockdowns and social distancing, the lack of mask use, the emergence of mutant strains of the virus and lower adherence by a sector of the global population that remains sceptical of the protection offered by vaccines, or about any risks associated with vaccines, hamper these efforts. Here we examine the literature on the efficacy, effectiveness and safety of COVID-19 vaccines, with an emphasis on select categories of individuals and against new SARS-CoV-2 strains. The literature shows that these eight vaccines are highly effective in protecting the population from severe disease and death, but there are some issues concerning safety and adverse effects. Further, booster shots and variant-specific vaccines would also be required.
引用
收藏
页码:91 / 104
页数:14
相关论文
共 50 条
  • [1] A Narrative Review of COVID-19 Vaccines
    Eroglu, Barbaros
    Nuwarda, Rina Fajri
    Ramzan, Iqbal
    Kayser, Veysel
    VACCINES, 2022, 10 (01)
  • [2] Effectiveness of COVID-19 vaccines and their challenges (Review)
    Marfe, Gabriella
    Perna, Stefania
    Shukla, Arvind Kumar
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2021, 22 (06)
  • [3] COVID-19, Vaccines, and Thrombotic Events: A Narrative Review
    Abrignani, Maurizio G.
    Murrone, Adriano
    De Luca, Leonardo
    Roncon, Loris
    Di Lenarda, Andrea
    Valente, Serafina
    Caldarola, Pasquale
    Riccio, Carmine
    Oliva, Fabrizio
    Gulizia, Michele M.
    Gabrielli, Domenico
    Colivicchi, Furio
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (04)
  • [4] The safety of Covid-19 mRNA vaccines: a review
    Pratibha Anand
    Vincent P. Stahel
    Patient Safety in Surgery, 15
  • [5] Review the safety of Covid-19 mRNA vaccines: a review
    Anand, Pratibha
    Stahel, Vincent P.
    PATIENT SAFETY IN SURGERY, 2021, 15 (01)
  • [6] Vaccines Developed against COVID-19: a narrative review
    Goncalves, Laura Faustino
    Stolz, Janaina Viana
    Haas, Patricia
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2021, 67 (04): : 625 - 631
  • [7] Feasibility and Effectiveness of Vaccines for COVID-19: An Umbrella Review
    SeyedAlinaghi, SeyedAhmad
    Pashapouryeganeh, Amirreza
    Dehghani, Soheil
    Mirzapour, Pegah
    Abbaspour, Faeze
    Afroughi, Fatemeh
    Rahimzadeh, Payman
    Najafi, Morvarid
    Ghasemi, Hoomaan
    Mozafari, Navid
    Soltanali, Zahra
    Mehraeen, Esmaeil
    ARCHIVES OF ACADEMIC EMERGENCY MEDICINE, 2025, 13 (01)
  • [8] Effectiveness, immunogenicity, and safety of COVID-19 vaccines for individuals with hematological malignancies: a systematic review
    Vanessa Piechotta
    Sibylle C. Mellinghoff
    Caroline Hirsch
    Alice Brinkmann
    Claire Iannizzi
    Nina Kreuzberger
    Anne Adams
    Ina Monsef
    Jannik Stemler
    Oliver A. Cornely
    Paul J. Bröckelmann
    Nicole Skoetz
    Blood Cancer Journal, 12
  • [9] Effectiveness, immunogenicity and safety of COVID-19 vaccines for individuals with haematological malignancies: a systematic review
    Mellingho, S.
    Piechotta, V
    Hirsch, C.
    Brinkmann, A.
    Iannizzi, C.
    Kreuzberger, N.
    Adams, A.
    Monsef, I
    Stemler, J.
    Cornely, O.
    Broeckelmann, P.
    Skoetz, N.
    ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 70 - 70
  • [10] Effectiveness, immunogenicity, and safety of COVID-19 vaccines for individuals with hematological malignancies: a systematic review
    Piechotta, Vanessa
    Mellinghoff, Sibylle C.
    Hirsch, Caroline
    Brinkmann, Alice
    Iannizzi, Claire
    Kreuzberger, Nina
    Adams, Anne
    Monsef, Ina
    Stemler, Jannik
    Cornely, Oliver A.
    Broeckelmann, Paul J.
    Skoetz, Nicole
    BLOOD CANCER JOURNAL, 2022, 12 (05)